A rational approach to evaluation of therapeutic equivalence of nanosimilars: a challenge for formulary selection

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: FLüHMANN, Beat (., Zürich, Switzerland)
  • Co-author(s): Beat Flühmann:
    Stefan Mühlebach: Regulatory Science, Vifor Pharma Ltd, Zürich, Switzerland
  • Abstract:

    Methods

    In a consensus round table with an international panel of leading hospital pharmacy experts , these evaluation criteria, were developed based on already existing criteria for biosimilars. An evaluation tool with a comprehensive checklist was elaborated.

    Results

    On top of existing criteria for biosimilars, a set of seven critical criteria..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login